Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0848283 (
rundown
)
502
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The epidermis, the outer layer of the skin composed of keratinocytes, is a stratified epithelium that functions as a barrier to protect the organism from dehydration and external insults. The epidermis develops depending on the transcription factor p63, a member of the p53 family of transcription factors. p63 is strongly expressed in the innermost basal layer where epithelial cells with high clonogenic and proliferative capacity reside. Deletion of p63 in mice results in a dramatic loss of all keratinocytes and loss of stratified epithelia, probably due to a premature proliferative
rundown
of the stem and transient amplifying cells. Here we report that microRNA (miR)-203 is induced in vitro in primary keratinocytes in parallel with differentiation. We found that miR-203 specifically targets human and mouse p63 3'-UTRs and not SOCS-3, despite bioinformatics alignment between miR-203 and SOCS-3 3'-
UTR
. We also show that miR-203 overexpression in proliferating keratinocytes is not sufficient to induce full epidermal differentiation in vitro. In addition, we demonstrate that miR-203 is downregulated during the epithelial commitment of embryonic stem cells, and that overexpression of miR-203 in rapidly proliferating human primary keratinocytes significantly reduces their clonogenic capacity. The results suggest that miR-203, by regulating the DeltaNp63 expression level, is a key molecule controlling the p63-dependent proliferative potential of epithelial precursor cells both during keratinocyte differentiation and in epithelial development. In addition, we have shown that miR-203 can regulate DeltaNp63 levels upon genotoxic damage in head and neck squamous cell carcinoma cells, thus controlling cell survival.
...
PMID:miR-203 represses 'stemness' by repressing DeltaNp63. 1848 91
Arc
is a unique immediate early gene (IEG) whose expression is induced as synapses are modified during learning. Newly-synthesized
Arc
mRNA is rapidly transported throughout dendrites and localizes near recently activated synapses.
Arc
mRNA levels are regulated by rapid degradation, which is accelerated by synaptic activity in a translation-dependent process. One possible mechanism is nonsense-mediated mRNA decay (NMD), which depends on the presence of a splice junction in the 3'
UTR
. Here, we test this hypothesis using transgenic mice that express
EGFP-Arc
. Because the transgene was constructed from
Arc
cDNA, it lacks intron structures in the 3'
UTR
that are present in the endogenous
Arc
gene. NMD depends on the presence of proteins of the exon junction complex (EJC) downstream of a stop codon, so
EGFP-Arc mRNA
should not undergo NMD. Assessment of
Arc
mRNA
rundown
in the presence of the transcription inhibitor actinomycin-D confirmed delayed degradation of
EGFP-Arc
mRNA.
EGFP-Arc
mRNA and protein are expressed at much higher levels in transgenic mice under basal and activated conditions but
EGFP-Arc
mRNA does not enter dendrites efficiently. In a physiological assay in which cycloheximide (CHX) was infused after induction of
Arc
by seizures, there were increases in endogenous
Arc
mRNA levels consistent with translation-dependent
Arc
mRNA decay but this was not seen with
EGFP-Arc
mRNA. Taken together, our results indicate: (1)
Arc
mRNA degradation occurs via a mechanism with characteristics of NMD; (2) rapid dendritic delivery of newly synthesized
Arc
mRNA after induction may depend in part on prior splicing of the 3'
UTR
.
...
PMID:Delayed Degradation and Impaired Dendritic Delivery of Intron-Lacking
EGFP
-
Arc
/
Arg3.1
mRNA in
EGFP-Arc
Transgenic Mice. 2944 24